Congress should fund a systematic review of the safety and efficacy of the most common dietary supplements, as outlined in a 2004 Institute of Medicine rep
The FDA should require supplement manufacturers’ labels to include possible supplement interactions with commonly prescribed prescription drugs.
Policymakers and others should explore reinsurance, risk adjustment, or similar mechanisms to spread the insurance risk more broadly.
Policymakers should ensure that state and federal health insurance marketplaces maintain an application-and-enrollment system and infrastructure that provi
Policymakers should support essential health benefit (EHB) requirements under the Affordable Care Act to ensure that consumers who purchase individual and
Policymakers should use cost-containment features, such as chronic disease management and incentives for administrative effectiveness (see also Private Health Plans: Manage
Policymakers should monitor these products to determine how they compare with traditional products.
Federal insurance reforms should apply equally to ERISA
AARP supports the overarching goals of the excise tax to achieve greater progressivity in the tax code and constrain health